The Association of Biotechnology Companies BioForum launches the #polishbiotech online database as the largest association of biotech companies in Poland.
We are the first point of contact for entrepreneurs in the biotechnology industry and we constantly support the Polish biotechnology community 👩🔬 👨🔬
SIGN UP HERE 👇👇👇
"*" indicates required fields
Zentiva Polska Sp. z o.o.
+ business areaBioPharma R&D+Services
+ annual revenue
2020 - 269,300,000 PLN
2021 - 295,700,000 PLN
2022 - 471,600,000 PLN
2023 - 467,100,000 PLN
2024 - 557,700,000 PLN
+ workforce (estimated if not reported)
2024 - 302
+ depreciation & amortization
2020 - 1,500,000 PLN
2021 - 952,100 PLN
2022 - 1,400,000 PLN
2023 - 1,100,000 PLN
2024 - 845,000 PLN
Zentiva Polska is a leading European pharmaceutical company specializing in generic medicines. Recently sold by Advent to GTCR, Zentiva emphasizes sustainable development with climate goals approved by SBTi. The company was recognized as one of the best workplaces in Poland in 2025, noted for inclusion and support of women and millennials. Zentiva focuses on cardiovascular health awareness and improving patient outcomes through generic pharmaceutical distribution and development.